Going to #NLASessions ? We have your Friday night covered! Support the Foundation of the NLA and bid on 2 tickets to Cirque du Soleil 'O'
nlafoundation.com

Thanks Pablo Corral MD for sharing this - Observational data & diet recall but compelling no less ! Of note those with ⬆️ Polygenic 🧬 Risk score for High Cholesterol did worse ( ? Hyper-absorbers ) .

Cardiovascular outcomes in patients with homozygous familial hyperchol...

Out now.

Well done all sciencedirect.com/science/articl…

Association of lipoprotein(a) and coronary artery calcium in asymptomatic patients: a systematic review and meta-analysis academic-oup-com.ezproxy.med.nyu.edu/eurjpc/article… Yet another reason to measure ! NYU CVD Prevention National Lipid Association Family Heart Foundation Foundation of the NLA #testlpa Via European Society of Cardiology Journals

Do you find it challenging to eat well when your schedule fills up?

Join us on 5/15 at 5 pm for a free webinar to hear clinical nutritionist, Heather Hodson, RD, share important strategies for making nutritious choices that fit into a busy lifestyle.

bit.ly/3sqnoO2

Can't make it to Vegas for #NLASessions ?

Join us virtually on Thursday, 5/30 to broaden your understanding of the complex nature of hyperlipidemia management: ow.ly/UBiW50RihOg

National Lipid Association Alan Brown MD MHA FACC FNLA Dr. James Underberg Christie Ballantyne Dr. Payal Kohli, MD

You can now watch our FREE on-demand #CME program with National Lipid Association! Join Dr. James Underberg (@lipiddoc), Dr. Alan Brown (@alanbrownmd), and Dr. Christie Ballantyne (@CBallantyneMD) for this discussion on #CETPinhibition ➡️ bit.ly/4bp07xh

Join NORD and Medlive for 8 easy-to-digest, on-demand #CME modules covering gene and cell therapies for several relevant disease states. Expert clinicians lead each module and review relevant data.

Start here: bit.ly/3w56Qxu

#CellTherapy #GeneTherapy

Coming 5/9/24: Watch our FREE on-demand #CME program with National Lipid Association on #CETP inhibition as a promising mechanism for reducing residual LDL-C elevation in patients at high cardiovascular risk ➡️ bit.ly/4bp07xh

🏷️ #MedicalEducation #MedEd #FreeCME #CVDisease

Sex differences in lipids: A life course approach - via Atherosclerosis #Atherosclerosis atherosclerosis-journal.com/article/S0021-… NYU CVD Prevention National Lipid Association Foundation of the NLA Family Heart Foundation

Expert Review from National Lipid Association Obesity Medicine Association Journal of Clinical Lipidology #Obesity , #dyslipidemia , and #cardiovasculardisease

How to diagnose rare diseases more accurately?
Use #AI
As shown with a new tool ai.marrvel.org
ai.nejm.org/doi/full/10.10…
Dongxue Mao Zhandong Liu Chaozhong Liu
Linhua (Alex) Wang sasidhar pasupuleti Rami Al-Ouran and colleagues BCMHouston NEJM AI

New Publication! Potential global implementation of #colchicine to target residual #inflammation in #CAD .

Kudos to Dr Michael Garshick, NYU Grossman School of Medicine cardiology fellow Dr Robert Zhang + collaborators Dr Brittany Weber and Dr Diego Araiza-Garaygordobil!

bit.ly/4cLBGLU

Bravo 👍👏

Faster CAC Progression After Menopause May Warrant Intensified Therapy tctmd.com/news/faster-ca…

Data from Bridge-TIMI 73a LBCT #Triglycerides reduced by 50% . Good safety Data. Via NEJM TIMI Study Group #ACC24 #lipids NYU CVD Prevention National Lipid Association Foundation of the NLA

#ACC24 Gregory Schwartz reminds ud that Ezetimibe is still underutilized and can add substantial benefits to reduce ASCVD outcomes when added to statins or other LDLc lowering therapies! #CardioTwitter #Cardiology

In FOURIER, intensive LDL-C lowering with #evolocumab led to greater CV event reduction in patients with autoimmune or inflammatory diseases. These patients may derive particular benefit from earlier, more intensive lipid-lowering treatments. Robert Giugliano André Zimerman #ACC24

Nice overview 👏of HDL space by Christie Ballantyne vijay nambi - “ injured reserve” HDL structure pic via Thomas Dayspring